|
FANCC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93019999983335E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.183350E-04 |
| Normal-vs-Stage2 |
3.204400E-02 |
| Normal-vs-Stage3 |
2.285000E-01 |
| Normal-vs-Stage4 |
9.780400E-01 |
| Stage1-vs-Stage2 |
7.661600E-01 |
| Stage1-vs-Stage3 |
4.090200E-01 |
| Stage1-vs-Stage4 |
2.061000E-01 |
| Stage2-vs-Stage3 |
6.159800E-01 |
| Stage2-vs-Stage4 |
1.742770E-01 |
| Stage3-vs-Stage4 |
4.702600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74770000005431E-06 |
| Normal-vs-AfricanAmerican |
2.475200E-03 |
| Normal-vs-Asian |
9.002200E-01 |
| Caucasian-vs-AfricanAmerican |
4.610600E-01 |
| Caucasian-vs-Asian |
3.052400E-01 |
| AfricanAmerican-vs-Asian |
2.508400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.02019999999892E-05 |
| Normal-vs-Female |
1.758910E-04 |
| Male-vs-Female |
2.194300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.949600E-02 |
| Normal-vs-Extreme_Weight |
6.901700E-03 |
| Normal-vs-Obese |
5.783400E-03 |
| Normal-vs-Extreme_Obese |
3.253600E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.577000E-01 |
| Normal_Weight-vs-Obese |
4.858200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.441800E-01 |
| Extreme_Weight-vs-Obese |
5.146800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.224600E-01 |
| Obese-vs-Extreme_Obese |
9.766600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.656400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.75660000013256E-07 |
| Normal-vs-Age(61-80Yrs) |
2.140700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.265800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.459620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.699000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.474000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.083400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.361900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.10149716809383E-11 |
| Normal-VS-Type2 PRCC |
8.915800E-01 |
| Normal-VS-KIRP CIMP |
2.619400E-01 |
| Normal-VS-Unclassified PRCC |
7.224200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.1077999961806E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.630500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.653600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.069200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.759700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.264400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.941600E-03 |
| Normal-vs-N1 |
3.312600E-01 |
| Normal-vs-N2 |
9.644400E-01 |
| N0-vs-N1 |
6.038400E-01 |
| N0-vs-N2 |
4.011200E-01 |
| N1-vs-N2 |
6.798800E-01 |
|
|
